Medigen Vaccine Biologics Corporation

Medigen Vaccine Biologics Corporationverified

6547.TWO

Price:

$39.65

Market Cap:

$13.03B

Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. The company is developing enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection; influenza vaccine, which has completed Phase III clinical trial to treat influenza; dengue vaccine, which has completed Phase II clinical trial for the treatment of dengue fever; respiratory cell fusion virus (RSV) antibody, which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19- severe special infectious pneumonia...[Read more]

Industry

Biotechnology

IPO Date

2015-09-16

Stock Exchange

TWO

Ticker

6547.TWO

The Current Ratio as of December 2025 (TTM) for Medigen Vaccine Biologics Corporation (6547.TWO) is 13.70

According to Medigen Vaccine Biologics Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 13.70. This represents a change of 7.56% compared to the average of 12.73 of the last 4 quarters.

Medigen Vaccine Biologics Corporation (6547.TWO) Historical Current Ratio (quarterly & annually)

How has 6547.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Medigen Vaccine Biologics Corporation over the last ten years is 8.27. The current 13.70 Current Ratio has changed 16.46% with respect to the historical average. Over the past ten years (40 quarters), 6547.TWO's Current Ratio was at its highest in in the March 2023 quarter at 26.39. The Current Ratio was at its lowest in in the September 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

8.27

Median

8.82

Minimum

2.21

Maximum

15.38

Medigen Vaccine Biologics Corporation (6547.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Medigen Vaccine Biologics Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 448.11%

Maximum Annual Current Ratio = 15.38

Minimum Annual Increase = -85.63%

Minimum Annual Current Ratio = 2.21

Quarterly (TTM)
Annual
YearCurrent RatioChange
202411.94440.14%
20232.21-85.63%
202215.3881.44%
20218.47-32.12%
202012.48448.11%
20192.28-59.44%
20185.62-4.66%
20175.89-35.72%
20169.16-1.01%
20159.26-20.80%

Medigen Vaccine Biologics Corporation (6547.TWO) Average Current Ratio

How has 6547.TWO Current Ratio performed in the past?

The current Current Ratio of Medigen Vaccine Biologics Corporation (6547.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

9.84

5-year avg

10.10

10-year avg

8.27

Medigen Vaccine Biologics Corporation (6547.TWO) Current Ratio vs. Peers

How is 6547.TWO’s Current Ratio compared to its peers?

Medigen Vaccine Biologics Corporation’s Current Ratio is less than AP Biosciences Inc (49.57), greater than PharmaEngine, Inc. (5.38), greater than Adimmune Corporation (2.00), less than Acepodia, Inc. (39.46), greater than Tanvex BioPharma, Inc. (2.17), greater than Foresee Pharmaceuticals Co., Ltd. (2.92), greater than Ever Supreme Bio Technology Co., Ltd (1.41), greater than TaiDoc Technology Corporation (2.29), greater than TaiDoc Technology Corporation (2.29), less than CHO Pharma, Inc. (21.85),

Build a custom stock screener for Medigen Vaccine Biologics Corporation (6547.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Vaccine Biologics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medigen Vaccine Biologics Corporation (6547.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medigen Vaccine Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Medigen Vaccine Biologics Corporation's Current Ratio?

How is the Current Ratio calculated for Medigen Vaccine Biologics Corporation (6547.TWO)?

What is the highest Current Ratio for Medigen Vaccine Biologics Corporation (6547.TWO)?

What is the 3-year average Current Ratio for Medigen Vaccine Biologics Corporation (6547.TWO)?

What is the 5-year average Current Ratio for Medigen Vaccine Biologics Corporation (6547.TWO)?

How does the current Current Ratio for Medigen Vaccine Biologics Corporation (6547.TWO) compare to its historical average?